Excessive glutamine sensitivity in Alzheimer's disease and Down syndrome lymphocytes.
In addition to clinical and neuropathological similarities between Alzheimer's disease and Down syndrome there are genetic and biochemical data which suggest common disease mechanism. Using an in vitro assay examining variations of the mitotic index in the presence or absence of various inhibitors or metabolites of purine and/or pyrimidine synthesis, we studied 19 Alzheimer disease patients and 16 patients with both Down syndrome and Alzheimer type dementia. A highly significant decrease in mitotic index in the presence of exogenous glutamine was noted in patients presenting an Alzheimer type dementia with or without associated Down syndrome. These findings suggest that glutamine sensitivity or some dysregulation of the glutamine/glutamate pathway may play a role in the pathogenesis of Alzheimer's disease. If these findings are confirmed, they would have important implications in the development of preventive strategies.
Peeters
M A
MA
Institut de Progénèse, Paris, France.
Salabelle
A
A
Attal
N
N
Rethore
M O
MO
Mircher
C
C
Laplane
D
D
Lejeune
J
J
D000328:Adult; D000544:Alzheimer Disease / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D016022:Case-Control Studies; D002478:Cells, Cultured; D004314:Down Syndrome / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D005973:Glutamine / Q000502:physiology / Q000633:toxicity*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008940:Mitotic Index / Q000187:drug effects
D005973:Glutamine